- Home
- IVT vs BHVN Comparison
IVT vs BHVN Comparison
Compare IVT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVT
- BHVN
- Stock Information
- Founded
- IVT 2005
- BHVN 2013
- Country
- IVT United States
- BHVN United States
- Employees
- IVT N/A
- BHVN N/A
- Industry
- IVT Real Estate Investment Trusts
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- IVT Real Estate
- BHVN Health Care
- Exchange
- IVT Nasdaq
- BHVN Nasdaq
- Market Cap
- IVT 2.3B
- BHVN 1.9B
- IPO Year
- IVT N/A
- BHVN 2017
- Fundamental
- Price
- IVT $27.99
- BHVN $15.67
- Analyst Decision
- IVT Buy
- BHVN Strong Buy
- Analyst Count
- IVT 5
- BHVN 14
- Target Price
- IVT $31.75
- BHVN $59.85
- AVG Volume (30 Days)
- IVT 341.3K
- BHVN 2.3M
- Earning Date
- IVT 04-30-2025
- BHVN 05-12-2025
- Dividend Yield
- IVT 3.41%
- BHVN N/A
- EPS Growth
- IVT 140.80
- BHVN N/A
- EPS
- IVT 0.24
- BHVN N/A
- Revenue
- IVT $280,947,000.00
- BHVN N/A
- Revenue This Year
- IVT $11.00
- BHVN N/A
- Revenue Next Year
- IVT $7.22
- BHVN $65.26
- P/E Ratio
- IVT $116.55
- BHVN N/A
- Revenue Growth
- IVT 7.90
- BHVN N/A
- 52 Week Low
- IVT $24.06
- BHVN $14.33
- 52 Week High
- IVT $31.65
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- IVT 50.24
- BHVN 37.55
- Support Level
- IVT $27.01
- BHVN $14.33
- Resistance Level
- IVT $28.31
- BHVN $15.94
- Average True Range (ATR)
- IVT 0.40
- BHVN 1.18
- MACD
- IVT 0.01
- BHVN -0.01
- Stochastic Oscillator
- IVT 51.58
- BHVN 19.73
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.